Dominique Monnet

Dominique Monnet

Direttore/Membro del Consiglio presso PDL BIOPHARMA, INC.
67 anni
Health Technology
Consumer Services
Electronic Technology

Profilo

Dominique P.
Monnet
currently works at PDL BioPharma, Inc., as Director and Noden Pharma DAC, as Director.
Mr. Monnet also formerly worked at Noden Pharma USA, Inc., as President & Director, Evofem Biosciences, Inc., as Director in 2019, Biotech Advisors International LLC, as Managing Director from 2013 to 2014, ALZA Corp., as General Manager, Amgen, Inc., as Vice President & GM-Inflammation Business Unit from 2011 to 2013, Ciba-Geigy Corp., as General Manager, Alexion Pharmaceuticals, Inc., as Chief Marketing Officer & Senior Vice President from 2014 to 2015, and Schering-Plough International, Inc., as General Manager.
Mr. Monnet received his Masters Business Admin degree from INSEAD and undergraduate degree from École des Hautes Études Commerciales du Nord.

Posizioni attive di Dominique Monnet

SocietàPosizioneInizio
PDL BIOPHARMA, INC. Direttore/Membro del Consiglio 31/12/2018
Direttore/Membro del Consiglio -

Precedenti posizioni note di Dominique Monnet

SocietàPosizioneFine
EVOFEM BIOSCIENCES, INC. Direttore/Membro del Consiglio 13/12/2019
ALEXION PHARMACEUTICALS, INC. Vendite & Marketing 01/10/2015
Biotech Advisors International LLC
Amministratore Delegato 01/05/2014
AMGEN INC. Corporate Officer/Principal 01/07/2013
Presidente -
Vedi nel dettaglio l'esperienza di Dominique Monnet

Formazione di Dominique Monnet

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

74

Relazioni di 1° grado

12

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private12

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Electronic Technology

Biotech Advisors International LLC

  1. Mercati
  2. Insiders
  3. Dominique Monnet
ULTIMI ORARI | -40%: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA